The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.
about
"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesInfluence of Acute and Chronic Exercise on Glucose UptakeHigh Mobility Group Box-1: A Missing Link between Diabetes and Its ComplicationsA high-fat diet impairs reproduction by decreasing the IL1β level in mice treated at immature stage.Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.Inflammation, metaflammation and immunometabolic disorders.Serglycin in Quiescent and Proliferating Primary Endothelial Cells.CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.Interleukin-1β mediates high glucose induced phenotypic transition in human aortic endothelial cells.Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 studyRelation between Arterial Stiffness and Markers of Inflammation and Hemostasis - Data from the Population-based Gutenberg Health Study.Multiple benefits of targeting inflammation in the treatment of type 2 diabetes.Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?Salivary microbiome of an urban Indian cohort and patterns linked to subclinical inflammation.Islet inflammation in type 2 diabetes and physiology.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.Commentary: Periodontal Treatment and Inflammation in Diabetes: Association or Causation?Lysosomal Ca2+ Signaling Regulates High Glucose-Mediated Interleukin-1β Secretion via Transcription Factor EB in Human Monocytic Cells.The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study.The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis.Plasma IL-1 Receptor Antagonist Concentration Has an Inverse Association With Birth Weight in Prepubertal Children.Evidence against a role for NLRP3-driven islet inflammation in db/db mice.Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling.Vitamin D Switches BAF Complexes to Protect β Cells.Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores.Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation.Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders
P2860
Q26747251-2D28FE53-424F-4AE9-8D26-FE67C7DFD0E3Q26748964-FCDAA457-146B-4E99-A964-DBE4C0665E92Q28066302-45DEE318-8370-454B-ACCF-AEB1238CA0D6Q33673768-430D6351-0AF6-4FFE-9958-80FFD2501B41Q33916655-ED3A94E6-5A95-4201-A3C4-F7A76A9D3424Q34550852-9337D5D5-BEB1-4E19-89D8-908803C77451Q35875577-5F32BE96-926A-46AE-AE62-D37730EC336BQ36278760-D3B81CEA-E801-490A-A5B8-99B5CAEFB4E9Q36654322-46C3499D-01E8-4C15-B430-A6F150D56C6FQ37615936-44C9F4FC-3904-4E33-8C84-3BB566A1183BQ38652417-5CDB2FD4-B5FA-4D74-8472-11FA117DA2F9Q38730213-2D47A6F8-8698-4911-9052-ECF49E0F30D0Q38845570-0BEB87F4-E47B-493F-B0C4-FD5EDC1CD5D3Q38850302-24DE26FA-0124-4354-B903-9A535719556EQ39065609-F7DDF003-7F74-4A92-B065-C2B87D073620Q39403443-F08890D8-4064-433C-AF4A-216A15AB9B07Q40066352-4A607F1B-EAC0-44F7-9BB1-5D2CD9E35151Q40563541-49BC7732-9433-47E7-941B-65A80AB5F107Q42362535-3F71F497-7B2F-4DF3-B72E-96CBA50CAB63Q45069046-39D4AED4-F27F-4DEA-BB4B-A78BACB5628AQ47124586-AEAC4A21-F8A7-4885-B356-DB9B61A77BC9Q47807059-A404B130-395D-48CE-9950-95A67F3B0C03Q47951650-8AC5C546-83CB-40F3-B297-767DBF668538Q51244047-8E04D90D-D917-49C9-A0BB-E897735F93BAQ52686204-1F4FB66A-BA79-4783-93CA-7275C7A91C1BQ53418749-D3A273F2-6D82-4E9E-B135-DB3F4CC33866Q53672883-4F95F061-02B6-4781-BBE9-7CC378D68AA0Q54224164-E8D6306A-BD19-4109-8EE7-58406ED71ACDQ55506522-2B0A59BB-E840-49F3-BE15-954C12AE061EQ57174315-FA5F2F51-0E6C-4383-8058-9CF8F33C7E2E
P2860
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.
@en
type
label
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.
@en
prefLabel
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.
@en
P2093
P1476
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
@en
P2093
Christian Herder
Marc Y Donath
Marianne Böni-Schnetzler
P304
P356
10.1016/J.TEM.2015.08.001
P50
P577
2015-10-01T00:00:00Z